Validated spectrophotometric methods for the estimation of moxifloxacin in bulk and pharmaceutical formulations

被引:72
作者
Motwani, Sanjay K. [1 ]
Chopra, Shruti [1 ]
Ahmad, Farhan J. [1 ]
Khar, Roop K. [1 ]
机构
[1] Fac Pharm, Dept Pharmaceut, New Delhi 110062, India
关键词
moxifloxacin; spectrophotometry; method validation; pharmaceutical dosage form;
D O I
10.1016/j.saa.2006.11.023
中图分类号
O433 [光谱学];
学科分类号
0703 ; 070302 ;
摘要
New, simple, cost effective, accurate and reproducible UV-spectrophotometric methods were developed and validated for the estimation of moxifloxacin in bulk and pharmaceutical formulations. Moxifloxacin was estimated at 296 nm in 0.1 N hydrochloric acid (pH 1.2) and at 289 nm in phosphate buffer (pH 7.4). Beer's law was obeyed in the concentration range of 1-12 mu g ml(-1) (r(2) = 0.9999) in hydrochloric acid and 1-14 mu g ml(-1) (r(2) = 0.9998) in the phosphate buffer medium. The apparent molar absorptivity and Sandell's sensitivity coefficient were found to be 4.63 x 10(4) l mol(-1) cm-(1) and 9.5 ng cm(-2)/0.001 A in hydrochloric acid; and 4.08 x 104 l mol(-1) cm(-1) and 10.8 ng cm(-2)/0.001 A in phosphate buffer media, respectively indicating the high sensitivity of the proposed methods. These methods were tested and validated for various parameters according to ICH guidelines. The detection and quantitation limits were found to be 0.0402, 0.1217 mu g ml(-1) in hydrochloric acid and 0.0384, 0.1163 mu g ml(-1) in phosphate buffer medium, respectively. The proposed methods were successfully applied for the determination of moxifloxacin in pharmaceutical formulations (tablets, i.v. infusions, eye drops and polymeric nanoparticles). The results demonstrated that the procedure is accurate, precise and reproducible (relative standard deviation <2%), while being simple, cheap and less time consuming and hence can be suitably applied for the estimation of moxifloxacin in different dosage forms and dissolution studies. (C) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:250 / 256
页数:7
相关论文
共 19 条
[1]  
Balfour JAB, 2000, DRUGS, V59, P115
[2]  
Balfour JAB, 1999, DRUGS, V57, P363
[3]  
Bolton S., 1997, PHARM STAT PRACTICAL, P216
[4]   Determination of ofloxacin and moxifloxacin and their penetration in human aqueous and vitreous humor by using high-performance liquid chromatography fluorescence detection [J].
Chan, Kwok Ping ;
Chu, Kai On ;
Lai, Wico Wai-Kwan ;
Choy, Kwong Wai ;
Wang, Chi Chiu ;
Lam, Dennis Shun-Chiu ;
Pang, Chi Pui .
ANALYTICAL BIOCHEMISTRY, 2006, 353 (01) :30-36
[5]   Voltammetric behaviour and determination of moxifloxacin in pharmaceutical products and human plasma [J].
Erk, N .
ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2004, 378 (05) :1351-1356
[6]  
*EUR AG EV MED PRO, 1996, GPMICH28195
[7]   Simultaneous determination of cefepime and the quinolones garenoxacin, moxifloxacin and levofloxacin in human urine by HPLC-UV [J].
González, JAO ;
Mochón, MC ;
de la Rosa, FJB .
MICROCHIMICA ACTA, 2005, 151 (1-2) :39-45
[8]   Determination of moxifloxacin (BAY 12-8039) in plasma and lung tissue by high-performance liquid chromatography with ultraviolet detection using a fully automated extraction method with a new polymeric cartridge [J].
Lemoine, T ;
Breilh, D ;
Ducint, D ;
Dubrez, J ;
Jougon, J ;
Velly, JF ;
Saux, MC .
JOURNAL OF CHROMATOGRAPHY B, 2000, 742 (02) :247-254
[9]   Separation of levofloxacin, ciprofloxacin, gatifloxacin, moxifloxacin, trovafloxacin and cinoxacin by high-performance liquid chromatography: application to levofloxacin determination in human plasma [J].
Liang, HR ;
Kays, MB ;
Sowinski, KM .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2002, 772 (01) :53-63
[10]  
Miller J Q, 1984, Med Sect Proc, P83